Skip to main content
. 2018 Nov 6;6(4):45. doi: 10.3390/proteomes6040045

Figure 6.

Figure 6

Expression of periplakin in a larger PDAC cohort and across multiple cancer types. mRNA expression of periplakin (PPL) is significantly higher in PDAC tumours (n = 39) than in normal pancreas (n = 39). Similarly, PPL mRNA expression is significantly highest in pancreatic cancer compared to 11 other cancer types. The Oncomine database (www.oncomine.org) was used to analyse our candidates’ expression in the Badea 2008 PDAC, and Ramaswamy multi-cancer microarray expression datasets.